Predictive Oncology Inc. (POAI)

Market Cap	13.21M
Revenue (ttm)	1.55M
Net Income (ttm)	-19.32M
Shares Out	4.03M
EPS (ttm)	-4.84
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,625
Open	3.13
Previous Close	3.16
Day's Range	3.13 - 3.29
52-Week Range	2.47 - 13.88
Beta	1.52
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 9, 2023

About POAI

Predictive Oncology Inc. operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples. It operates through four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomi...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2002
• Employees: 31
• Stock Exchange: NASDAQ
• Ticker Symbol: POAI

Financial Performance

In 2022, POAI's revenue was $1.51 million, an increase of 5.97% compared to the previous year's $1.42 million. Losses were -$25.74 million, 30.9% more than in 2021.